Macular degeneration and glaucoma can both lead to vision loss. However, macular degeneration tends to affect central vision while glaucoma affects side vision. The causes and treatment are also ...

Myopia, or nearsightedness, is a common eye condition. More than 40% of Americans can't see clearly at a distance because their eye is longer than normal. Usually myopia doesn't cause any problems ...

Macular degeneration affects the macula, a part of the retina at the back of the eye. Doctors often refer to it as age-related macular degeneration (AMD). There are two types of macular degeneration: ...

Quitting smoking and getting regular eye exams may lower your risk of macular degeneration. Eating a Mediterranean diet can reduce your risk of advanced AMD by 41%. You can wear sunglasses that block ...

The macula is the center part of your retina. It gives you your central vision, what you see right in front of you. When the macula is damaged, you can still see around the edges of your vision, ...

Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book pages and ...

Age-related macular degeneration, also called AMD, is the deterioration of the center of the retina called the macula. The macula is the part of the retina which is responsible for our central vision ...

Macular degeneration is the leading cause of vision loss in people older than 65. Smoking doubles your risk of macular degeneration compared to non-smokers. Your risk of the disease increases if you ...

There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it happens when small deposits form under the retina, causing cells in the ...

A new federally funded research effort in Rochester is aiming to tackle one of the biggest gaps in treating age-related macular degeneration — stopping vision loss before it starts. Researchers at ...

Advances in neovascular macular degeneration, as presented at the American Society of Retina Specialists (ASRS) 2025 annual meeting, include data on efficacy and dosing intervals for aflibercept 8 mg ...